WallStreetZenWallStreetZen

NASDAQ: IMNM
Immunome Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immunome earnings were -$293.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IMNM earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$80.2M, up 70.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMNM reported annual earnings of -$293.0M, with 174.3% growth. The next IMNM earnings date is May 12, 2025.

IMNM earnings history

Current Revenue
$9.0M
Current Earnings
-$293.0M
Current Profit Margin
-3,240.4%

IMNM Return on Equity

Current Company
-125.3%
Current Industry
-2%
Current Market
34.1%
IMNM's Return on Equity (-125.3%)... subscribe to Premium to read more.
High Return on Equity Performance

IMNM undefined

Current Company
-105.3%
Current Industry
-0.4%
IMNM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMNM announces earnings.

IMNM undefined

Current Company
-157.56%
Current Industry
5.9%
IMNM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMNM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMNM-$290.86M-$292.96MN/A-$5.00
XNCR-$182.25M-$232.62MN/A-$3.58
NUVB-$567.09M-$567.94MN/A-$2.11
QURE-$160.75M-$239.56MN/A-$4.92
PRAX-$181.53M-$182.82MN/A-$10.21
View Top Biotech Stocks

IMNM earnings dates

Next earnings date
May 12, 2025

Immunome Earnings Reports & History FAQ

What were Immunome's earnings last quarter?

On IMNM's earnings call on Invalid Date, Immunome (NASDAQ: IMNM) reported Q4 2024 earnings per share (EPS) of -$1.28, up 69.67% year over year. Total IMNM earnings for the quarter were -$80.25 million. In the same quarter last year, Immunome's earnings per share (EPS) was -$4.22.

If you're new to stock investing, here's how to buy Immunome stock.

When does Immunome report earnings?

The next IMNM earnings date is Invalid Date. Add IMNM to your watchlist to be reminded of Immunome's next earnings date.

Is Immunome profitable or losing money?

As of the last Immunome earnings report, Immunome is currently losing money. Immunome's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$292.96 million, a 174.29% increase year over year.

What was IMNM's earnings growth in the past year?

As of Immunome's earnings date in Invalid Date, Immunome's earnings has grown year over year. IMNM earnings in the past year totalled -$292.96 million.

What are Immunome's earnings expectations?

The current EPS estimate for Immunome's earnings report in Invalid Date is -$0.81.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.